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Key PointsUse of MDTs is a global trend in disease management, while China is still at the exploratory stageOur MDT includes skilled epileptologists, electroencephalography experts, neurosurgeons, child neurologists, radiologists, and psychiatristsOne thousand 88 consecutive patients were reviewed from March 2013 to December 2017MDT discussion contributes to attaining accurate diagnosis and favorable seizure outcomesThere is still room for MDT improvement in resource‐limited countries

1. INTRODUCTION {#epi412290-sec-0006}
===============

Epilepsy is an important public health problem that affects over 50 million people worldwide.[1](#epi412290-bib-0001){ref-type="ref"} In China, the prevalence of epilepsy is more than 9 million, and another 450 000 new cases are diagnosed annually.[2](#epi412290-bib-0002){ref-type="ref"} Uncontrolled seizures have a negative impact on a patient(\'s quality of life, particularly the social, economic, and cognitive aspects.[3](#epi412290-bib-0003){ref-type="ref"}, [4](#epi412290-bib-0004){ref-type="ref"}, [5](#epi412290-bib-0005){ref-type="ref"} Although most patients respond well to antiepileptic drugs (AEDs), approximately one‐third will become drug‐resistant and only 4% acquire seizure freedom through additional pharmacotherapy after failure of 2 first‐line AEDs.[6](#epi412290-bib-0006){ref-type="ref"}, [7](#epi412290-bib-0007){ref-type="ref"}, [8](#epi412290-bib-0008){ref-type="ref"} Thus, epilepsy surgery is increasingly being considered as an important treatment option for intractable epilepsy, and comprehensive preoperative assessment is essential for epilepsy surgery.[9](#epi412290-bib-0009){ref-type="ref"}

Presurgical evaluation involves multiple disciplines, including but not limited to neurology, electroencephalography, neuroradiology, neurosurgery, and neuropsychology. The multidisciplinary team (MDT) is a global trend in disease management; however, use of MDTs for epilepsy management has sprung up in China only in recent years. Epilepsy centers in resource‐limited countries usually lack sufficient evaluation technologies, such as positron emission tomography/computed tomography (PET/CT), single‐photon emission computed tomography (SPECT), functional magnetic resonance imaging (fMRI), electrocorticography (ECoG), and stereo‐electroencephalography (SEEG). In addition, the high costs of these technologies without medical insurance coverage largely limit their use.[10](#epi412290-bib-0010){ref-type="ref"}, [11](#epi412290-bib-0011){ref-type="ref"} To address these concerns, it is necessary to understand the current epilepsy MDT situation in resource‐limited countries, especially in China. However, up to now, there has been no published research revealing the relevant MDT experience.

This present study aimed to summarize our experience with MDT and assess its effect on screening surgical candidates, managing patients with epilepsy and optimizing their seizure outcomes.

2. METHODS {#epi412290-sec-0007}
==========

2.1. Subjects {#epi412290-sec-0008}
-------------

We established an MDT in the epilepsy center of West China Hospital in March 2013. Patients were discussed in our MDT once a week before 2017 and twice a week in 2017 and later. Our MDT consists of experienced adult epileptologists, child neurologists, electroencephalography experts, neurosurgeons, radiologists, and psychiatrists. Epileptologists were responsible for epilepsy diagnoses, management, and presurgical evaluation. Neurosurgeons were responsible for operation and also participated in presurgical evaluation. Electroencephalography experts helped analyzing electroencephalography (EEG) results, whereas radiologists assisted with interpreting the neuroimaging findings. Because there were no neuropsychologists or neuropsychiatrists in our center, we called upon experienced psychiatrists to provide differential diagnoses and address psychiatric concerns, and to manage epilepsy‐related neuropsychological or neuropsychiatric problems.

Consecutive patients were included in this study from March 2013 to December 2017. The inclusion criteria were as follows: (a) patients with a definite diagnosis of epilepsy according to the 2010 International League Against Epilepsy (ILAE) classification[12](#epi412290-bib-0012){ref-type="ref"} and willingness to undergo surgery; (b) patients with a definite diagnosis of epilepsy and ineffective drug treatment; and (c) patients who were prediagnosed as having epilepsy but the diagnosis was doubted by other neurologists.

2.2. MDT protocol {#epi412290-sec-0009}
-----------------

The MDT discussion followed a similar pattern: (a) detailed collection of clinical history, video‐EEG, and neuroimaging findings; (b) discussion on the diagnosis and seizure type; (c) suggestions for management according to different diagnoses; and (d) face‐to‐face communication with patients and their families. Detailed MDT protocol is shown in Figure [1](#epi412290-fig-0001){ref-type="fig"}. After MDT discussion and epilepsy surgery, patients were followed up every 6 months to assess their seizure outcomes. Surgical outcomes were evaluated according to the Engel classification.[13](#epi412290-bib-0013){ref-type="ref"}

![MDT assessment process. ACTH, adrenocorticotropic hormone; AEDs, antiepileptic drugs; CC, corpus callosotomy; DBS, deep brain stimulation; EEG, electroencephalography; f‐MRI, functional MRI;KD, ketogenic diet; MDT, multidisciplinary team; MRI, magnetic resonance imaging; PET/CT, positron emission tomography/computed tomography; VEEG, video‐electroencephalography; VNS, vagus nerve stimulation](EPI4-4-85-g001){#epi412290-fig-0001}

2.3. Statistical analysis {#epi412290-sec-0010}
-------------------------

Detailed clinical characteristics, suggestions, and follow‐up data were collected and analyzed. Age is shown as median, whereas other data are shown as means. Data were analyzed in terms of percentages. Excel (2016; Microsoft) and SPSS (version 20.0; IBM) was used for analysis.

3. RESULTS {#epi412290-sec-0011}
==========

3.1. Demographics {#epi412290-sec-0012}
-----------------

A total of 1088 patients (604 male, 484 female) were included in this study. Most patients were referred by clinicians in an outpatient clinic. The number of patients at MDT discussion increased gradually every year (Figure [2](#epi412290-fig-0002){ref-type="fig"}).

![Tendency of MDT assessment](EPI4-4-85-g002){#epi412290-fig-0002}

The median age of patients at MDT discussion was 21 years (range 10 months to 79 years). Patients younger than 18 years of age accounted for 35.6%. The median age at seizure onset was 12 years (range 2 days to 77 years). The mean course of disease was 8.8 years. Explicit family history of epilepsy was found in 9 patients and febrile convulsion history was found in 54 patients (5%). Most patients had at least one seizure per month and took 2 or more AEDs. A total of 768 patients (70.6%) met the standard of drug‐resistant epilepsy: failure of adequate trials of 2 tolerated and appropriately chosen and used AED schedules (whether as monotherapy or in combination) to achieve sustained seizure freedom.[8](#epi412290-bib-0008){ref-type="ref"} No obvious poor compliance or inappropriate lifestyle was found. Although blood concentrations were not monitored regularly, the daily doses of 2 previous AEDs reached their 50% defined daily dose (DDD). Almost all patients underwent brain MRI. The most common etiology was structural abnormality, especially hippocampal sclerosis. Ictal EEG was captured in nearly half of the patients, whereas PET/CT was performed in only small portion. Furthermore, there was no SPECT or SEEG data. Details are provided in Table [1](#epi412290-tbl-0001){ref-type="table"}.

###### 

Demographic characteristics of patients

  Variable                                                    No.   \%
  ----------------------------------------------------------- ----- ------
  Sex                                                               
   Male                                                       604   55.5
   Female                                                     484   44.5
  Age at discussion (y)                                             
   0‐6                                                        70    6.4
   7‐12                                                       123   11.3
   13‐17                                                      194   17.8
   18‐65                                                      690   63.4
   \>65                                                       11    1.0
  Disease duration (y)                                              
   \<2                                                        196   18.0
   2‐10                                                       476   43.8
   \>10                                                       416   38.2
  Febrile convulsion history                                  54    5.0
  Seizure type                                                      
   Generalized seizures                                       206   18.9
   Focal seizures                                             750   68.9
   Generalized combine focal seizures                         113   10.4
   Unknown                                                    19    1.8
  Seizure frequency                                                 
   Daily                                                      253   23.3
   Weekly                                                     276   25.3
   Monthly                                                    374   34.4
   \>Monthly                                                  185   17.0
  AEDs (numbers)                                                    
   \<2                                                        249   22.9
   =2                                                         352   32.3
   \>2                                                        487   44.8
  Ictal EEG                                                   534   49.0
  PET/CT                                                      130   11.9
  Etiology                                                          
   Genetic                                                    9     0.8
   Structural                                                 725   66.6
   Hippocampal sclerosis                                      198   27.3
   Encephalomalacia[a](#epi412290-note-0002){ref-type="fn"}   137   18.9
   Cerebral dysplasia                                         106   14.6
   Neoplasia                                                  63    8.7
   Vascular malformation                                      60    8.3
   Others                                                     161   22.2
   Metabolic                                                  4     0.4
   Immune                                                     3     0.3
   Infectious                                                 41    3.8
   Unknown                                                    306   28.1

AEDs, antiepileptic drugs; EEG, electroencephalography; PET/CT, positron emission tomography/computed tomography.

Caused by head trauma or intracranial surgery.

John Wiley & Sons, Ltd

3.2. MDT evaluation results {#epi412290-sec-0013}
---------------------------

After comprehensive assessment, different suggestions were given from MDT, including AEDs adjustion, resective surgery, SEEG, vagus nerve stimulation, ketogenic diet, adrenocorticotropic hormone, or symptomatic treatment. (Table [2](#epi412290-tbl-0002){ref-type="table"}). A definite diagnosis of epilepsy was made for 1070 patients according to the 2010 International League Against Epilepsy (ILAE) classification. Among these patients, 382 (35.1%) were suitable for resective surgery and 261 of the 382 had undergone the surgery before 2018. Other patients with epilepsy were advised to adjust AEDs, wait for SEEG evaluation, or consider other options, such as vagus nerve stimulation (VNS), adrenocorticotropic hormone (ACTH), ketogenic diet (KD), or corpus callosotomy (CC). In addition, 18 patients were diagnosed as having nonepileptic diseases and were advised to withdraw AEDs and begin symptomatic treatment if necessary. Their details were shown in Table [3](#epi412290-tbl-0003){ref-type="table"}.

###### 

MDT evaluation results

  Suggestion              No.   \%
  ----------------------- ----- ------
  Adjust AEDs             581   53.4
  Resective surgery       382   35.1
  SEEG                    72    6.6
  VNS                     20    1.8
  KD                      9     0.8
  ACTH                    6     0.6
  Symptomatic treatment   18    1.7

AEDs, antiepileptic drugs; ACTH, adrenocorticotropic hormone; KD, ketogenic diet; SEEG, stereo‐electroencephalography; VNS, vagus nerve stimulation.

John Wiley & Sons, Ltd

###### 

Details of nonepileptic seizures

  Disease                             No.
  ----------------------------------- -----
  Psychogenic nonepileptic seizure    6
  Syncope                             4
  Sleep disorders                     3
  Paroxysmal kinesigenic dyskinesia   3
  Withdrawal symptom                  1
  Cerebral palsy                      1

John Wiley & Sons, Ltd

3.3. Surgical outcomes {#epi412290-sec-0014}
----------------------

Up to the end of 2017, subdural EEG was performed in 28 patients (2.6%). Only one patient (1/28, 3.6%) sustained a subdural hematoma, which was removed in the subsequent resection surgery. Clear localization of the epileptogenic focus was achieved in 24 patients, who underwent further resection surgery.

Among the 211 patients who underwent resective surgery and were followed up for more than 1 year, 24 (11.4%) were lost to follow‐up and 136 of the remaining 187 (72.7%) had favorable seizure outcomes (Engel class I). Detailed surgical outcome data are presented in Table [4](#epi412290-tbl-0004){ref-type="table"}. Most surgeries (70.1%) were temporal lobe surgery. The seizure‐free rate of temporal lobe surgery was 78.6%, whereas that of extratemporal lobe surgery was 58.9%. Obvious neurologic deficits persistented in 6 patients (3.2%), including hemiplegia in 3 patients, hearing loss in 2 patients, and hydrocephalus in one patient. In addition, 4 patients (2.1%) died during the follow‐up period. Only one patient (0.5%) died of postoperative brain hemorrhage, swelling, and infection. The other 2 died of tumor recurrence and one died of suicide. Unfortunately, the quality of life was not assessed.

###### 

Seizure outcomes after resective surgery

                    Resective surgery (N = 187)   
  ----------------- ----------------------------- ------------
  Engel class I     103 (78.6%)                   33 (58.9%)
  Engel class II    12 (9.2%)                     6 (10.7%)
  Engel class III   8 (6.1%)                      12 (21.4%)
  Engel class IV    8 (6.1%)                      5 (8.9%)

John Wiley & Sons, Ltd

3.4. Outcomes of nonsurgical cases {#epi412290-sec-0015}
----------------------------------

Outcomes of patients for whom resection surgery was not recommended are shown in Table [5](#epi412290-tbl-0005){ref-type="table"}. To better evaluate the effects, we included only the patients who were followed for more than 1 year. And we divided the effects into improved (symptom control ≥50%) and unimproved group (symptom control ˂50%). Because SEEG was not carried out before 2018, those patients were still on the waiting list. Besides, the outcomes of other treatments, such as AED adjustment, VNS, KD, ACTH, or symptomatic treatment, were not as good as resection surgery.

###### 

Outcomes of nonsurgical cases (follow‐up ˃1 y)

  Treatments              No.   Symptom improved (control ≥50%)   Symptom unimproved (control ˂50%)
  ----------------------- ----- --------------------------------- -----------------------------------
  Adjust AEDs             306   89 (29.1%)                        217 (70.9%)
  VNS                     5     2 (40%)                           3 (60%)
  KD                      2     1 (50%)                           1 (50%)
  ACTH                    4     1 (25%)                           3 (75%)
  Symptomatic treatment   13    5 (38.5%)                         8 (61.5%)

AEDs, antiepileptic drugs; ACTH, adrenocorticotropic hormone; KD, ketogenic diet; VNS, vagus nerve stimulation.

John Wiley & Sons, Ltd

4. DISCUSSION {#epi412290-sec-0016}
=============

MDTs are a global trend in disease management, whereas in resource‐limited countries, epilepsy MDTs have become available only in recent years. Epilepsy management requires not only a team of experienced specialists but also expensive electrophysiologic and neuroimaging equipment. In other words, epilepsy MDTs depend a lot on the economic and resource level of a country. In resource‐limited countries, most epilepsy centers lack sufficient evaluation technologies, such as high‐resolution MRI, PET/CT, SPECT, f‐MRI, ECoG, and SEEG. Furthermore, most of these techniques cost a lot, without medical insurance covered. Thus there may be some differences between resource‐limited and resource‐rich countries in MDT establishment and practice. However, these data on epilepsy MDT are barely reported in resource‐limited countries, especially in China. Thus, we hope to offer insight into the situation of epilepsy MDTs in resource‐limited countries. We reviewed 1088 consecutive patients with epilepsy surgery who were willing to be discussed at our MDT in West China Hospital from March 2013 to December 2017. Some of our findings were in line with those or resource‐rich countries, whereas others were different, as expected.

The seizure‐free rate from epilepsy surgery can reach 70%, or even higher[14](#epi412290-bib-0014){ref-type="ref"}; however, in resource‐limited countries, only a limited number of patients have a correct understanding of epilepsy surgery and opportunities to acquire professional presurgical evaluation. That is why we established our MDT---to help manage epilepsy patients and screen appropriate surgical candidates. Because more and more patients and even doctors acknowledge the advantages of MDTs, the number of patients at our MDT discussion increased gradually every year, from 67 in 2013 to 363 in 2017. Most of our patients who were discussed at our MDT were recommended by clinicians at outpatient clinics after initial consultation on epilepsy surgery and basic tests of video‐EEG and brain MRI scan, which, to a great extent, guarantee the quality of the MDT discussion. In addition, there were still a small number of patients with a strong desire for surgery but some confusing attacks which might not be true seizures. Accurate diagnosis may become the most important goal of the MDT discussion. Most MDT procedures followed similar patterns. After an initial consult in the outpatient clinic, most patients were advised to complete a basic examination, such as EEG and brain MRI. If this patient was potentially suitable for epilepsy surgery, met the standard of drug‐resistant epilepsy, or had some confusing symptoms, he or she would be advised to attend our first MDT discussion. For the first MDT discussion, a detailed clinical history, video‐EEG, and neuroimaging findings would be carefully collected. The MDT would discuss their diagnoses and give them individualized suggestions face to face. If the condition of the patient is not clear or this patient has intractable focal epilepsy, further testing would be advised and a second or third MDT discussion would be carried out. After an MDT discussion and epilepsy surgery, patients would be followed up at an outpatient clinic or by phone to assess their seizure outcomes.

Different from some other epilepsy centers, our MDT included adult epileptologists and child neurologists; hence 35.6% of our patients were younger than 18 years of age. Although pediatric epilepsy is different from adult epilepsy and it seemed suitable for younger patients to remain in a pediatric epilepsy center, there was no special pediatric neurosurgery in our pediatric hospital and our pediatric hospital only treated patients younger than age 14. Thus children with epilepsy who were suitable for surgery or older than age 14 had to find a new neurosurgeon or adult neurologist. Our MDT could offer some help with that. It also reflected a good cooperation between adult and pediatric epilepsy services and offered a convenient transition from a pediatric to an adult epilepsy care center.[15](#epi412290-bib-0015){ref-type="ref"}

Similar to most epilepsy centers, most of our patients had drug‐resistant epilepsy, which was necessary for them to start presurgical evaluation. Presurgical evaluation was indeed the main purpose of our MDT conference. The average epilepsy duration before our MDT evaluation was 8.8 years, which was shorter than the 10 years mentioned in a previous study.[16](#epi412290-bib-0016){ref-type="ref"} The result reflected the increasing awareness of surgery in resource‐limited countries. In our study, video‐EEG and brain MRI were the most common assessment measures. And the proportion of positive MRI findings reached 74.2%, which meant most of our cases were of symptomatic epilepsy. The most common structural abnormality discussed at our MDT was hippocampal sclerosis, followed by encephalomalacia caused by head trauma or intracranial surgery. If the patients symptoms and EEG and MRI findings were coincident, surgery was advised, with no need for additional measurements.[17](#epi412290-bib-0017){ref-type="ref"} If the patients symptoms and EEG and MRI findings were discordant or MRI was negative, further PET/CT or subdural electrode implantation were advised. However, many patients gave up trying these tests because of the expensive without insurance coverage. Furthermore, we had not used SEEG and SPECT in our epilepsy center because of lack of relevant equipment or support technology.

After MDT discussion, 18 patients were confirmed as having nonepileptic seizures, including psychogenic nonepileptic seizure, syncope, sleep disorder, paroxysmal kinesigenic dyskinesia, withdrawal symptoms, and cerebral palsy. It may be because many local doctors lacked adequate knowledge of differential diagnosis in this resource‐limited country. MDT discussion may be a good solution for this. In addition, 35.1% patients were suitable for resective surgery. The high proportion of surgical candidates may result from our high proportion of symptomatic epilepsy. The others were advised to adjust AEDs or consider other options, such as VNS, corpus callosotomy, ACTH, or KD. However, limited by the expensive and relative low efficacy rates, these other options were rarely chosen in low‐income patients. Otherwise, different from other resource‐rich countries, deep brain stimulation or laser therapy for epilepsy was not carried out at our center.

In our study, a total of 72.7% patients received favorable seizure outcomes (Engel class I) for at least 1 year. The seizure‐free rate after temporal lobe surgery was 78.6%, and 58.9% after extratemporal surgery. These results were better than those of previous studies. As reported in the first randomized controlled study of temporal lobe epilepsy, the seizure‐free rate at 1 year was 58%.[18](#epi412290-bib-0018){ref-type="ref"} Some other studies summarized the mean seizure free rate as 62.4%‐66% for temporal lobe resection and 27%‐46% for extratemporal resections.[9](#epi412290-bib-0009){ref-type="ref"}, [14](#epi412290-bib-0014){ref-type="ref"}, [19](#epi412290-bib-0019){ref-type="ref"} Reasons might include our more cautious attitude toward resective surgery, the relatively short follow‐up duration, and more common temporal lobe epilepsy with hippocampal sclerosis, which was thought to be one of the best fits for surgery.

There are several limitations to this study. Although our sample size reached 1088, this was still a single‐center study, which may not fully reflect the whole situation of epilepsy MDT in China. Therefore, a larger multicenter cohort study or a national action is needed to confirm these results. Second, the minimum of our follow‐up time was only 1 year, which may weaken our findings. We will continue our follow‐up and solve this problem in the future. Third, our MDT is still at an early stage. Our assessment measures and treatment options are less than what is available in resource‐rich countries. This will be improved, since our SPECT, SEEG, and deep brain stimulation will be put into use soon. Last but not least, we had to face the fact that we lacked skilled neuropsychological and neuropsychiatric members and related facilities. We could not professionally assess a patients treatment compliance, neuropsychological or neuropsychiatric state, the quality of life, and so on. We will pay more attention to these aspects in our further work and we are committed to cultivating our own professionals in these fields.

In conclusion, skilled team members, more optional assessment technologies, standard assessment protocol, and increased government and insurance interventions are important to improve our MDT for epilepsy management.[20](#epi412290-bib-0020){ref-type="ref"}
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